• About
    • About Seattle DogSpot
    • My Dogs
  • Lost Dogs
    • Lost Dog Tips
    • Post Your Lost Dog
  • Adoption & Rescue Tips
  • Advertise
    • Get Featured
    • Free Dog-Friendly Business Decal
  • Contact Us

Seattle DogSpot

Follow Seattle DogSpot on FacebookFollow Seattle DogSpot on InstagramFollow Seattle Dogspot on TwitterFollow Seattle DogSpot on PinterestFollow Seattle DogSpot on YouTube
  • Home
  • Dog News
    • Local News
    • Recalls
  • Dog Friendly Seattle
    • Dog Friendly Businesses
    • Dog Friendly Hotels
  • Where to Play
    • Seattle Area Dog Events
    • Dog Parks
    • Travel With Your Dog
  • Happy Healthy Dog
    • Dog Health & Wellness
    • Dog Training & Behavior
  • Dog Events
    • Master Events Calendar
    • Submit an Event
  • Reviews
You are here: Home / Dog News / FDA warns Washington companies producing cannabis pet products about marketing claims

FDA warns Washington companies producing cannabis pet products about marketing claims

March 16, 2015 by Seattle DogSpot Leave a Comment

Share This!

KOMO News reported last week that the Food and Drug Administration (FDA) sent letters to 2 Washington based companies that produce cannabis pet products to stop making unproven medical claims. 

The 2 companies are Canna Pet in Seattle and Canna Companion in Sultan. 

Image from Cannabis Culture.

Image from Cannabis Culture.

The important thing to remember is that the FDA is not saying that selling cannabis for pets is illegal. Instead, according to an article in the Seattle Times, the FDA “took issue with the companies’ marketing, specifically claims that the products help with symptoms of cancer, dementia and asthma.”

The Times also reported that a senior advisor at the FDA said in an email that the companies were selected for warning letters “in part, based on the egregiousness of the therapeutic claims made about their products and the determination that inaction posed a potential risk to public health.”

Here are some of the claims on the Canna Companion website the FDA cited in its letter:

Under the heading “Here’s how Canna Companion may help your dog or cat:

“Reduce cancer-associated symptoms”
“Aid in decreasing severity of dementia”
“Reduce bronchial spasms in asthmatics”

“CBD Antibacterial . . . Inhibits cancer cell growth . . . Reduces blood sugar levels … Reduces inflammation, Reduces risk of artery blockage, . . . Slows bacterial growth, . . . Treats psoriasis”

Under the heading “Scientific”:
o “CBD . . . Antidiabetic, . . . Antimicrobial, Antineoplastic, Anti-proliferative, Antipsoriatic, Antipsychotic. . . .” (http://www.cannaforpets.com/scientific).

The letters also noted that “to be legally marketed, a new animal drug must have an approved new animal drug application, conditionally approved new animal drug application, or index listing…”

This same rule applies to claims about herbal supplements like echinacea.

Canna Pet is one of the two WA companies that received warning letters from the FDA about how they market cannabis for pets. Image from Canna Pet.

Canna Pet is one of the two WA companies that received warning letters from the FDA about how they market cannabis for pets. Image from Canna Pet.

We bought cannabis from both Canna Pet and Canna Companion for our dog Dylan last summer to ease the pain of arthritis, and it appeared to us that it help him. I would try it again if we ever have a pet that could benefit from it.

The one thing about this story that concerned me is the level of cannabinoids the FDA found in products from Canna Pet and Canna Companion. Cannabinoids are the chemical compound in cannabis that can provide relief to pain, inflammation, and nausea, but the products the FDA tested had tiny levels of cannabinoids, and one didn’t have any.

But Canna Companion co-owner Lisa Anderson told the Times that “it’s not just the CBD that helps ease symptoms, but other compounds in the formula help as well.”

I don’t remember the level of cannabinoids in the products we gave Dylan, but as I said, they appeared to diminish his symptoms.

The companies that received warning letters have 15 days to let the FDA know what they have done to correct the violations.

Anderson told the Times that Canna Pet “was adjusting its website and working with the FDA to fix any problems.”

While we think cannabis helped our dog, dog owners must decide for themselves if they should give it to their pet and understand that its medical benefits have not been tested by the FDA. They should also consult with their veterinarian.

Share This!

Filed Under: Dog News Tagged With: Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

www.metrodogseattle.com

www.raindogphoto.com

Find info on more events...

Recent Articles

  • Ginger’s Pet Rescue Paid Over $140k to Staff, Charged Average of $1400+ for Dog Adoption in 2022
  • Will Grays Harbor County Finally Take Action Against Backyard Breeder?
  • Puyallup Dog Rescue Importing Underage Puppies from Mexico
  • Dogs from Furever Homes Rescue Kill Neighbor’s Goats in Olympia
  • Do NOT Adopt a Belgian Malinois After Watching DOG

[Read more…]

This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to the use of cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. Cookie Policy

Find it here

Contact:

Seattle DogSpot
info@seattledogspot.com

Return to Top of Page

Copyright © 2025 Seattle DogSpot | Seattle Web Design by Original Ginger

Terms of Use | Privacy Policy | Refund & Return Policy

 

Loading Comments...